Last reviewed · How we verify

Moxonidin — Competitive Intelligence Brief

Moxonidin (MOXONIDINE) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: moxonidine. Area: Cardiovascular.

marketed moxonidine Nischarin Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Moxonidin (MOXONIDINE).

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Moxonidin TARGET MOXONIDINE marketed moxonidine Nischarin 1991-01-01
Zanaflex TIZANIDINE Legacy Pharma Usa marketed Central alpha-2 Adrenergic Agonist Nischarin 1996-01-01
Tenex GUANFACINE Promius Pharma marketed Central alpha-2 Adrenergic Agonist Nischarin 1986-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (moxonidine class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Moxonidin — Competitive Intelligence Brief. https://druglandscape.com/ci/moxonidine. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: